Drug Type Small molecule drug |
Synonyms Choline cocrystal of epalrestat, Choline diepalrestat + [1] |
Target |
Mechanism AKR1B1 inhibitors(Aldose reductase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2/3 |
First Approval Date- |
Regulation- |
Molecular FormulaC35H39N3O7S4 |
InChIKeyWKSNHZZSMLFYFI-UROVXFGGSA-M |
CAS Registry1665300-21-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic peripheral neuropathy | Phase 3 | RU | 01 Nov 2014 | |
Diabetic peripheral neuropathy | Phase 3 | RU | 01 Nov 2014 |